We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Tests on Day of Discharge Are Often Never Seen

By HospiMedica International staff writers
Posted on 06 Sep 2012
The results of tests ordered on the day of a patient's discharge from the hospital made up a disproportionate number of tests that doctors never reviewed, according to a new study. More...


Researchers at the Australian Institute of Health Innovations (Sydney, Australia), and St Vincent's Hospital (Sydney, Australia) reviewed data on 662,858 clinical pathology tests ordered during 6,736 inpatient admissions at a single hospital. In all, more than one-third of admissions (37.7%) had at least one test that was not reviewed before discharge, and 28% had unreviewed results two months postdischarge. Of these, test results that were still pending--and thus, not yet available--at discharge accounted for only 28.6% of the tests that were not reviewed.

After analysis, the researchers found that although only a fraction of all tests were ordered on the day of discharge, those ordered on the last day of the hospital stay accounted for nearly half (46.8%) of tests that were not reviewed at discharge, and 41.1% of those that had not been looked at by two months. Of all of the unreviewed tests, 14.7% of those at discharge and 10.8% of those at two months later had abnormal test results. In all, about two-thirds of all unreviewed, abnormal results came from tests ordered on the day of discharge. The study was published online as a research letter on August 13, 2012, in Archives of Internal Medicine.

“When discharge dates are known, or the average length of stay for an admission is well defined, it would be possible to estimate the time available for review,” suggested lead author to Enrico Coiera, MBBS, PhD. “This information can be used to trigger computer alerts when tests are being ordered electronically. Alerts could advise clinicians either that it is unlikely those results will be posted before discharge, or that the tests simply have a high risk of being missed.”

Related Links:

Australian Institute of Health Innovations
St Vincent's Hospital



Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
ECG Management System
NEMS Web
Infant Resuscitator
Easypuff
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.